Atossa Therapeutics, Inc.ATOSNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-26.29M
↓ 78% vs avg
Percentile
P0
Near historical low
Streak
9 yr
Consecutive declineContracting
Average
$-14.73M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-26.29M | -24.9% |
| 2024 | $-21.05M | -0.4% |
| 2023 | $-20.95M | -0.8% |
| 2022 | $-20.79M | -26.1% |
| 2021 | $-16.48M | -42.3% |
| 2020 | $-11.58M | -26.7% |
| 2019 | $-9.14M | -0.7% |
| 2018 | $-9.07M | -37.6% |
| 2017 | $-6.59M | -22.5% |
| 2016 | $-5.38M | - |